Enhancing Medical Device Postmarketing Safety Surveillance-The Case of Inferior Vena Cava Filters

Behnood Bikdeli^{1

2}, Joseph S Ross^{2

3

4}

Affiliations

¹ Division of Cardiovascular Medicine and the Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
² Center for Outcomes Research & Evaluation, Yale-New Haven Hospital, New Haven, Connecticut.
³ Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
⁴ Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.

Comment

Behnood Bikdeli et al. JAMA. 2024.

. 2024 Dec 24;332(24):2065-2067.

doi: 10.1001/jama.2024.19542.

Behnood Bikdeli^{1

2}, Joseph S Ross^{2

3

4}

¹ Division of Cardiovascular Medicine and the Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
² Center for Outcomes Research & Evaluation, Yale-New Haven Hospital, New Haven, Connecticut.
³ Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
⁴ Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.

No abstract available

Comment on

Postmarketing Surveillance of Inferior Vena Cava Filters Among US Medicare Beneficiaries: The SAFE-IVC Study.
Ferro EG, Mackel JB, Kramer RD, Torguson R, Whatley EM, O'Connell G, Pullin B, Watson NW, Li S, Song Y, Krawisz AK, Carroll BJ, Schermerhorn ML, Weinstein JL, Farb A, Zuckerman B, Yeh RW, Secemsky EA. Ferro EG, et al. JAMA. 2024 Dec 24;332(24):2091-2100. doi: 10.1001/jama.2024.19553. JAMA. 2024. PMID: 39504004 Free PMC article.